BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.2.3.1//EN TZID:America/Phoenix X-WR-TIMEZONE:America/Phoenix BEGIN:VEVENT UID:1512@azbio.org DTSTART;TZID=America/Phoenix:20200916T090000 DTEND;TZID=America/Phoenix:20200916T100000 DTSTAMP:20200821T024713Z URL:https://www.azbio.org/events/new-uses-for-existing-drugs-applications- for-covid-19-and-valley-fever SUMMARY:New Uses for Existing Drugs: Applications for COVID-19 and Valley F ever  - - 16 Sep 20 09:00 DESCRIPTION:\n \;\nNew Uses for Existing Drugs: Applications for COVID- 19 and Valley Fever \;\n\n\nWhat is drug repurposing and why is it imp ortant?\n\nLearn more about the \;CURE ID web-based app made possible by the National Center for Advancing Translational Sciences (NCATS) and it s utility for COVID-19 and Valley Fever.\n\nHealth care professionals are encouraged to attend. \;\n\nPresented by:\n Marco Schito\, PhD\nExecut ive Director\, Cure Drug Repurposing Collaboratory \;\nMarco Schito\, PhD \;is Executive Director of C-Path’s CURE Drug Repurposing Collab oratory and an Adjunct Professor at the University of Arizona\, James E. R ogers College of Law. His work aims to discover potentially safe and effec tive repurposed therapies for diseases with high unmet medical need by cap turing and sharing global\, real-world clinical data. Prior to joining C-P ath\, Dr. Schito was a Senior Scientific Officer at the Division of AIDS\, NIH where he wrote and managed point-of-care diagnostic contracts for dev eloping HIV viral load assays in low-resource settings\, stood up a fully- characterized HIV global viral diversity panel program\, and launched a re search initiative to standardize the measurement of mucosal immune respons es in HIV clinical trials. During his intramural tenure at the National Ca ncer Institute\, Dr. Schito led the in vivo modeling of anti-retroviral zi nc finger inhibitors\, characterized TCR transgenic murine models\, and th e immune characterization of mice deficient in p53 phosphatases (PPM1D). O ver the past decade\, he established data knowledgebase to enable the use of Next Generation Sequencing platforms to quickly and accurately identify efficacious tuberculosis drug regimens. This platform is now being used b y the World Health Organization for their global genomic drug surveillance program. Dr. Schito received his PhD from the Ontario Veterinary College at the University of Guelph\, Canada in immuno-parasitology.\n\n \;\n\ n END:VEVENT BEGIN:VTIMEZONE TZID:America/Phoenix X-LIC-LOCATION:America/Phoenix BEGIN:STANDARD DTSTART:20190917T090000 TZOFFSETFROM:-0700 TZOFFSETTO:-0700 TZNAME:MST END:STANDARD END:VTIMEZONE END:VCALENDAR